Dglifzar is an oral antidiabetic tablet containing Dapagliflozin, a sodium-glucose co-transporter-2 (SGLT2) inhibitor that helps improve glycemic control in adults with Type 2 diabetes mellitus when used alongside diet and exercise. https://telizar.com/dglifzar/